ArticleBMC public health2026
Understanding perceptions towards COVID-19 vaccination and strategies to increase vaccine uptake among Ebola- affected communities in North Kivu, Democratic Republic of the Congo: a qualitative study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNorth Kivu, in eastern Democratic Republic of the Congo (DRC), was the epicenter of the second largest Ebola Virus Disease (EVD) outbreak in history and has been an active conflict zone for decades. The COVID-19 pandemic further exacerbated an already complex situation. This qualitative study, conducted as part of a broader investigation into Ebola vaccine hesitancy and at the onset of COVID-19 vaccination rollout in the DRC, assessed perceptions, beliefs, and attitudes toward the COVID-19 virus and vaccines among community members and healthcare workers who had experienced the 2018-2020 EVD outbreak, during which a novel vaccine was also administered.
methodsBetween May and June 2021, thirty-three focus group discussions (FGDs) and fifteen key informant interviews were conducted across three health zones that had offered Ebola vaccination (rVSV-ZEBOV) during the 2018-2020 EVD outbreak. Participants included healthcare workers (HCWs) and community members, as well as leaders, administrative officials, and frontline workers who had supported outbreak response and vaccination services.
resultsAcross all locations and groups, perceived risk of COVID-19 was low, with many participants doubting its existence and relevance, particularly when compared to other needs and endemic health conditions in their communities. COVID-19 was believed to primarily affect white, affluent individuals in urban areas, and not those residing in hot climates. Vaccine hesitancy was driven by perceived insufficient transparency and communication regarding COVID-19 vaccines, including questions about their composition, potential side effects, and rationale behind prioritizing certain groups. COVID-19 vaccine perceptions also reflected broader concerns, including mistrust of the government and rumors related to past Ebola outbreaks and vaccination efforts. To increase uptake, respondents recommended ensuring COVID-19 vaccination is voluntary and free of charge, working with non-traditional local demand generation and vaccination actors, strengthening local vaccine production capacity, and increasing the impact of interpersonal communication through social media messaging.
conclusionsThese findings add to growing evidence on how prior exposure to another disease of international concern (Ebola) and the associated vaccine, as well as historical context, influence perceptions of novel vaccines. Community engagement and tailored communication to address community concerns and misinformation are essential to building trust. Policymakers and implementers should consider more innovative approaches for developing and implementing vaccination policies in collaboration with local actors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.